Format

Send to

Choose Destination
Diabetes Technol Ther. 2015 Sep;17(9):664-6. doi: 10.1089/dia.2014.0328. Epub 2015 Apr 29.

Cybersecurity in Artificial Pancreas Experiments.

Author information

1
1 Division of Endocrinology, Mayo Clinic , Rochester, Minnesota.
2
2 Center for Diabetes Technology, University of Virginia , Charlottesville, Virginia.

Abstract

Medical devices have transformed modern health care, and ongoing experimental medical technology trials (such as the artificial pancreas) have the potential to significantly improve the treatment of several chronic conditions, including diabetes mellitus. However, we suggest that, to date, the essential concept of cybersecurity has not been adequately addressed in this field. This article discusses several key issues of cybersecurity in medical devices and proposes some solutions. In addition, it outlines the current requirements and efforts of regulatory agencies to increase awareness of this topic and to improve cybersecurity.

PMID:
25923544
PMCID:
PMC4556085
DOI:
10.1089/dia.2014.0328
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center